140 
MR. HUTT: Two further questions, then. First, has research been 
undertaken or is it being undertaken to resolve whatever risk-assessment 
is necessary on that specific point, or is that the kind of experiment you 
were talking about earlier? 
DR. ROWE: It is the kind that is under this indefinite delay, yes. 
MR. HUTT: It is? Okay. The second is, Is that kind of research that 
cannot go forward now because it is in P4 , is that the kind that is being 
placed in P3 abroad? 
DR. ROWE: Yes. 
DR. FREDRICKSON: Mr. Helms. 
MR. HELMS: When will the evidence be in from abroad, at least satisfac 
tory to the Committee, that if they are doing these experiments and people 
are not dropping like flies, what should we wait for, how long until we have 
something publishable? 
DR. FREDRICKSON: I think maybe it would be useful to have Dr. Tooze 
join us at this moment. He is scheduled to be an invited witness, but it 
will be on this very subject. Don't you think you would like to precede the 
plant viruses or plant problems? You want to talk about this particularly, 
don't you? 
DR. TOOZE: Yes. 
DR. FREDRICKSON: Then why don't you take the podium. Excuse me, 
though — before you do that, Professor Rosenblith had a question. 
PROFESSOR ROSENBLITH: I am starting to feel distinctly uncomfortable. 
We are faced with a draft and we are now hearing one testimony after another 
that this is a political draft, that it has been done for reasons that per- 
haps the Committee is not comfortable with. I have here a testimony of Dr. 
Szybalski which he just distributed which certainly goes further in that di- 
rection. What are we faced with, Mr. Chairman? Would you care to explain 
that to us? 
DR. FREDRICKSON: Well, I think we could serially ask the members of 
the Advisory Committee who are here, but I think that I would gather from 
the sum of testimony that you have heard thus far that the Committee feels 
that it has been extremely conservative in making recommendations, at least 
in this particular area. Many questions have been asked of Dr. Rowe. I 
think it is perhaps — if I am not accurate someone should stop me — he is one 
of the ranking viral experts on this Committee; he has a vested interest in 
a number of the experiments that relate to the use of some of these viruses; 
and he has--I presume it would be feasible to believe that he may well have 
erred on the side of extreme conservatism, perhaps to avoid any appearance 
of conflict of interest. These are among some of the aspects which seem to 
be undertones of some of the discussion you have heard. 
[ 344 ] 
